Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1951 1
1952 6
1953 3
1954 5
1955 3
1956 2
1957 1
1958 2
1959 2
1962 1
1963 2
1964 4
1965 2
1966 5
1968 3
1969 4
1971 8
1972 2
1973 2
1974 2
1975 4
1976 6
1977 3
1978 6
1979 4
1980 3
1981 2
1982 3
1983 4
1984 4
1985 3
1986 1
1987 1
1988 5
1989 6
1990 4
1991 1
1992 6
1993 3
1994 2
1995 3
1996 3
1997 5
1998 3
1999 2
2000 2
2001 1
2002 1
2003 1
2004 4
2006 1
2007 1
2008 2
2010 1
2011 2
2013 1
2015 1
2018 3
2022 1
2023 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

171 results

Results by year

Filters applied: . Clear all
Page 1
Rationale for the use of baroceptor stimulators.
Sapru HN, Krieger AJ. Sapru HN, et al. J Surg Res. 1978 Jul;25(1):77-82. doi: 10.1016/0022-4804(78)90162-2. J Surg Res. 1978. PMID: 355726 Review. No abstract available.
Baroceptor function in chronic renal hypertension.
MCCUBBIN JW, GREEN JH, PAGE IH. MCCUBBIN JW, et al. Circ Res. 1956 Mar;4(2):205-10. doi: 10.1161/01.res.4.2.205. Circ Res. 1956. PMID: 13293821 No abstract available.
Effects of baroceptor reflex on cardiac and renal sympathetic nerve activity before and after atropinization in awake cats at rest.
Ninomiya I, Matsukawa K, Honda T, Nishiura N, Nabuchi A. Ninomiya I, et al. Jpn J Physiol. 1988;38(4):491-506. doi: 10.2170/jjphysiol.38.491. Jpn J Physiol. 1988. PMID: 3236570
During the rising MAP period, the gain of the baroceptor-sympathetic system decreased to 0.91 and 0.97 in MCSNA and MRNA, respectively. During the returning MAP period, a delayed activation in MCSNA and MRNA occurred centrally. We conclude that the baroceptor reflex …
During the rising MAP period, the gain of the baroceptor-sympathetic system decreased to 0.91 and 0.97 in MCSNA and MRNA, respectivel …
RENAL BAROCEPTOR CONTROL OF RENIN SECRETION.
SKINNER SL, MCCUBBIN JW, PAGE IH. SKINNER SL, et al. Science. 1963 Aug 30;141(3583):814-6. doi: 10.1126/science.141.3583.814. Science. 1963. PMID: 14045137
Release of reruin appears to be mediated by a renal baroceptor rather than by ischemia....
Release of reruin appears to be mediated by a renal baroceptor rather than by ischemia....
Drug therapy for the patient with resistant hypertension.
Donazzan L, Ewen S, Papademetriou V, Linicus Y, Linz D, Böhm M, Mahfoud F. Donazzan L, et al. Future Cardiol. 2015 Mar;11(2):191-202. doi: 10.2217/fca.15.9. Future Cardiol. 2015. PMID: 25760878 Review.
Role of receptor elements in baroceptor resetting.
Sapru HN, Krieger AJ. Sapru HN, et al. Am J Physiol. 1979 Jan;236(1):H174-82. doi: 10.1152/ajpheart.1979.236.1.H174. Am J Physiol. 1979. PMID: 434168
On the other hand, baroceptor resetting in untreated SHR was always accompanied by significant changes in vascular wall, and reversal of baroceptor resetting was contingent upon regression of vascular wall hypertrophy. Partial baroceptor resetting in absence …
On the other hand, baroceptor resetting in untreated SHR was always accompanied by significant changes in vascular wall, and reversal …
Device-based therapies for resistant hypertension.
Bruno RM, Di Giulio A, Bernini G, Virdis A, Ghiadoni L, Taddei S. Bruno RM, et al. Curr Pharm Des. 2013;19(13):2401-8. doi: 10.2174/1381612811319130008. Curr Pharm Des. 2013. PMID: 23173589 Review.
Novel non-pharmacological, promising approaches targeting sympathetic nervous system are now available, such as renal denervation and baroceptor-activating therapy. This review is aimed at describing essential clinical aspects of resistant hypertension, physiopatological b …
Novel non-pharmacological, promising approaches targeting sympathetic nervous system are now available, such as renal denervation and bar
171 results